Jinneng Science & Technology Co Inventory
The Inventory of Jinneng Science & Technology Co (603113.SS) as of Oct 10, 2026 is 1.42 B CNY. In the previous year, Inventory was 1.61 B CNY — a change of -11.71% (lower).
Get this data via API
Financial Data API
Inventory
1.42 BCNY
YoY
-11.71%
Last updated:
The Jinneng Science & Technology Co Inventory history
3 Years
10 Years
25 Years
Max
| YEAR | Inventory | YoY |
|---|---|---|
| 1.42 BCNY | -11.71% | |
| 1.61 BCNY | +43.98% | |
| 1.12 BCNY | +11.67% | |
| 1.00 BCNY | -12.87% | |
| 1.15 BCNY | +110.77% | |
| 545.90 MCNY | -3.81% | |
| 567.54 MCNY | +2.79% | |
| 552.14 MCNY | +5.60% | |
| 522.87 MCNY | +8.09% | |
| 483.73 MCNY | +63.35% | |
| 296.14 MCNY | -18.61% | |
| 363.83 MCNY | — |
Jinneng Science & Technology Co Stock analysis
Frequently Asked Questions about Jinneng Science & Technology Co stock
Inventory of Jinneng Science & Technology Co is 1.42 B CNY in 2025.
Inventory of Jinneng Science & Technology Co changed from 1.61 B CNY to 1.42 B CNY, representing a -11.71% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Inventory Jinneng Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.
Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.
Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Jinneng Science & Technology Co historically and in real time.
Balance Sheet — Jinneng Science & Technology Co
All Key Metrics — Jinneng Science & Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth